GL1X · GenesisL1 explorer

MolNFT v1 · #127088 · protein

Vim-2_2B. metallo-beta-lactamase inhibitors by bioisosteric replacement: preparation, activity and binding

5MM9 · Metallo-beta-lactamase vim-17: “Vim-2_2B. metallo-beta-lactamase inhibitors by bioisosteric replacement: preparation, activity and binding”. X-ray diffraction, 3 ligands (8SH, ZN, MG), 2 pockets (best druggability 0.73). MolNFT v1…

PDB
5MM9
Type
protein
Length
463 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Metallo-beta-lactamase vim-17
UniProt
B5KVR9
Ligands
8SH, ZN, MG
Pockets
2 · best druggability 0.73

Structure

x-ray diffraction · 2 distinct chains · 27% helix, 29% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMetallo-beta-lactamase vim-17protein23227% helix, 29% strandB5KVR9
BMetallo-beta-lactamase vim-17protein23127% helix, 29% strandB5KVR9

Ligands and binding sites

  • 8SH · (2~{R})-2-diethoxyphosphoryl-5-phenyl-pentane-1-thiol · ligand · 2 copies · chains A, B
  • ZN · Zinc ion · metal · 6 copies · chains A, B
  • MG · Magnesium ion · metal · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16060.730.8055ZN, 8SH
2520.320.7718empty

Interfaces

1 interface between chains.

  • A–B · 578 Ų buried · 11 hydrogen bonds · protein-protein

Compared structures

  • 5MM9 · VIM-2_2b. Metallo-beta-Lactamase Inhibitors by Bioisosteric Replacement: Preparation… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.